SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-009945
Filing Date
2022-05-16
Accepted
2022-05-16 07:38:35
Documents
13
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmea-20220516.htm   iXBRL 8-K 50720
2 EX-99.1 bmea-ex99_1.htm EX-99.1 136534
  Complete submission text file 0000950170-22-009945.txt   318625

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmea-20220516.xsd EX-101.SCH 2507
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmea-20220516_pre.xml EX-101.PRE 10395
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmea-20220516_lab.xml EX-101.LAB 14110
7 EXTRACTED XBRL INSTANCE DOCUMENT bmea-20220516_htm.xml XML 4934
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 22925517
SIC: 2834 Pharmaceutical Preparations